LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation-Reference-Cited by-同舟云学术

LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation

Published:2021-04 Issue: Volume:503 Page:138-150
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chen Lei,Wang Yue-Yang^ORCID,Li Deng,Wang Cheng,Wang Shi-Yuan,Shao Si-Hui,Zhu Zheng-Yang^ORCID,Zhao Jing,Zhang Yu^ORCID,Ruan Yuan,Han Bang-Min,Xia Shu-Jie,Jiang Chen-Yi,Zhao Fu-Jun

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference63 articles.

1. Androgen receptor signaling in prostate cancer;Culig;Canc. Metastasis Rev.,2014

2. Androgen receptors in hormone-dependent and castration-resistant prostate cancer;Shafi;Pharmacol. Ther.,2013

3. Therapeutic targeting of the prostate cancer microenvironment;Karlou;Nat. Rev. Urol.,2010

4. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages;Niu;Proc. Natl. Acad. Sci. U. S. A.,2008

5. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome;Leach;Oncotarget,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia;Biology Direct;2024-08-02

2. Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor;Frontiers in Immunology;2024-05-28

3. Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

4. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials;Molecular Cancer;2023-10-02

5. LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1;Cell Death & Disease;2023-08-12